Medicating Children : : ADHD and Pediatric Mental Health / / Rick Mayes, Jennifer Erkulwater, Catherine Bagwell.

• Superior document: Title is part of eBook package: De Gruyter HUP eBook Package Archive 1893-1999
• VerfasserIn: Mayes, Rick,; Bagwell, Catherine,; Erkulwater, Jennifer,
• Place / Publishing House: Cambridge, MA : : Harvard University Press, , [2009]; ©2009
• Year of Publication: 2009
• Language: English
• Physical Description: 1 online resource (360 p.)
• Other title: Frontmatter --; Contents --; Acknowledgments --; Chapter one. Introduction --; Chapter two. An Introduction to ADHD --; Chapter three. A Survey of the Evolution of ADHD and Pediatric Stimulant Use, 1900–1980 --; Chapter four. The Transformation of Mental Disorders in the 1980s: The DSM-III, Managed Care, and “Cosmetic Psychopharmacology” --; Chapter five. ADHD and the Politics of Children’s Disability Policy --; Chapter six. The Backlash against ADHD and Stimulants --; Chapter seven. Current Questions about Stimulant Treatment for ADHD --; Chapter eight. Conclusion --; Notes --; Selected Bibliography --; Index
• Format: Mode of access: Internet via World Wide Web.
• ISBN: 9780674275126; 9783110442212; 9783110442205
• DOI: 10.4159/9780674275126?locatt=mode:legacy
• Access: restricted access
• Hierarchical level: Monograph
• Statement of Responsibility: Rick Mayes, Jennifer Erkulwater, Catherine Bagwell.

Why and how did ADHD become the most commonly diagnosed mental disorder among children and adolescents, as well as one of the most controversial? Stimulant medication had been used to treat excessively hyperactive children since the 1950s. And the behaviors that today might lead to an ADHD diagnosis had been observed since the early 1930s as “organic drivenness,” and then by various other names throughout the decades. Rick Mayes and colleagues argue that a unique alignment of social and economic trends and incentives converged in the early 1990s with greater scientific knowledge to make ADHD the most prevalent pediatric mental disorder. New movements advocating for the rights of children and the disabled and a massive increase in Medicaid spending on psychotropic drugs all contributed to the dramatic spike in ADHD diagnoses and stimulant use. Medicating Children is unique in that it integrates analyses of the clinical, political, historical, educational, social, economic, and legal aspects of ADHD and stimulant pharmacotherapy. Thus, it will be invaluable to educators, clinicians, parents, and policymakers, all of whom are trying to determine what is in the best interest of millions of children.